Status:
COMPLETED
Safety and Efficacy Study of Bimatoprost, Latanoprost, and Travoprost in Patients With Elevated Intraocular Pressure (IOP) and Open-angle Glaucoma (OAG)
Lead Sponsor:
Allergan
Conditions:
Open-Angle Glaucoma
Ocular Hypertension
Eligibility:
All Genders
18+ years
Brief Summary
To investigate the effectiveness of the newer IOP-lowering therapies, as prescribed in normal clinical practice, in larger patient numbers. Patients will be assessed at baseline, at each follow-up vis...
Eligibility Criteria
Inclusion
- A diagnosis of Primary Open-Angle Glaucoma or Ocular Hypertension newly diagnosed OR presenting with insufficiently controlled IOP on current medication (in the opinion of the treating physician)
- Patient is having both eyes treated
Exclusion
- Contraindications per product labelling will apply.
- Patients with any ophthalmic co-morbidity with an influence on visual field deterioration or optic nerve head damage.
Key Trial Info
Start Date :
September 1 2004
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 1 2009
Estimated Enrollment :
1099 Patients enrolled
Trial Details
Trial ID
NCT00716742
Start Date
September 1 2004
End Date
September 1 2009
Last Update
January 6 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Murfreesboro, Tennessee, United States